Non-invasive, automated heart health checker for early heart failure and pulmonary hypertension
Official title: A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension
Funded at Sensydia Corporation · NIH-11322000 · Data updated 2026-11-12
A new non-invasive device platform aims to measure four key heart-hemodynamics (EF, CO, PAP, PCWP) safely at home or in basic clinics to help people at risk of heart failure or pulmonary hypertension.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sensydia Corporation NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | May 5, 2023 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $816,106 |
| NIH project number | 5R42HL167342-03 |
| Project ID | NIH-11322000 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older who are at risk for heart failure or pulmonary hypertension.
✕Less likely to help
Patients without heart conditions or those not needing hemodynamic monitoring may not benefit.
What this research studies
This project offers an automated, non-invasive tool that can estimate important heart health metrics without the need for risky catheterization or specialized staff. It seeks to provide results comparable to invasive methods, potentially enabling earlier diagnosis and ongoing monitoring for people with or at risk of heart failure or pulmonary hypertension. The device is designed to be easy to use, potentially expanding access to key diagnostics beyond high-resource centers. Patients may benefit from safer, more affordable testing and closer surveillance of their heart condition as it progresses or responds to treatment.
Why it matters
Potential benefit: If successful, patients could receive safer, cheaper, and more accessible heart health assessments with timely guidance for treatment decisions.
How similar studies have gone: Previous methods rely on invasive catheterization or specialized imaging; this work seeks a non-invasive alternative with comparable accuracy.
Where this research is happening
-
Sensydia Corporation
Los Angeles, United States Active
Researchers
- Principal investigator: Mahajan, Aman — Sensydia Corporation
- Study coordinator: Mahajan, Aman
Related research
Other NIH-funded projects on the same topics.
-
Right heart muscle mechanics in pulmonary hypertension with heart failure
Researchers are studying how the right heart muscle fails in people who have heart failure with reduced ejection fraction and high blood pressure in the lungs, to improve diagnosis and care.
-
Understanding heart muscle function in patients with heart failure and pulmonary hypertension
This study is looking at how well the right side of the heart works in people with heart failure and high blood pressure in the lungs, especially during exercise, to find out more about problems that doctors might not usually catch, which could help improve how we diagnose and treat these conditions.
-
A non-invasive tool to assess heart function and risk of heart failure.
This study is working on a new, easy-to-use tool that can safely check how well your heart is working without any invasive procedures, making it especially helpful for people at risk of heart failure or pulmonary hypertension.
-
Using Metformin to Treat Pulmonary Hypertension in Heart Failure Patients
This study is looking at how the diabetes medication metformin might help older patients with heart failure and high blood pressure in the lungs, especially those with metabolic syndrome, to see if it can improve their heart and lung function.
-
Understanding how CD4 T cells fuel schistosomiasis-related lung disease
A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.
-
CD4 T Cells, Schistosoma, and Pulmonary Hypertension: Understanding How Immune Cells Drive Disease
A human-health focused study uses a mouse model and human samples to explore how immune cells and inflammation may contribute to a lung blood vessel disease linked to schistosomiasis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.